Vera Therapeutics, Inc. VERA

Rank #2432 · Nasdaq · $2.2B market cap

Audited by KPMG LLP, no going-concern flag in the latest filing.

Score

19.1

P/E

-23.2

P/B

28.92

ROE

-124.8%

Op. Margin

–%

Debt Ratio

102%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆

Poor

P/E -23.2x, P/B 28.92x. Ranks in the top 84% of the universe.

Profitability ★☆☆☆☆

Poor

ROE -124.8%. Ranks in the top 95% of the universe.

Safety ★★★☆☆

Good

Debt ratio 102%. Ranks in the top 40% of the universe.

Growth –

No data

Not enough historical filings to compute year-over-year growth yet.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2021	–	$-0.1B	$-0.1B	$-0.0B	–	-12
2022	–	$-0.0B	$-0.0B	$-0.1B	–	-16
2023	–	$-0.1B	$-0.1B	$0.1B	–	78
2024	–	$-0.1B	$-0.1B	$0.1B	–	96
2025	–	$-0.1B	$-0.1B	$0.1B	–	102